Do LEP rs7799039 and LEPR rs1137101 variants alter leptin signaling and energy-balance regulation?

The regulation of appetite and energy balance is heavily dependent on the leptin signaling pathway, a feedback loop between adipose tissue and the hypothalamus. Research indicates that specific genetic variations in the leptin gene (LEP) and its receptor (LEPR) can significantly modulate this system's efficiency.

Clinical and effectiveness evidence

The LEP rs7799039 and LEPR rs1137101 variants are consistently associated with metabolic phenotypes related to obesity and weight management.

• LEP rs7799039 (G-2548A): Meta-analyses of over 10,000 subjects show that this promoter variant is a significant predictor of circulating leptin levels. While effects can vary by ethnicity, the A allele is frequently linked to higher serum leptin and increased obesity risk, with odds ratios typically ranging from 1.2 to 1.5.
• LEPR rs1137101 (Gln223Arg): This variant is strongly associated with increased Body Mass Index (BMI) and type 2 diabetes risk. Individuals with the GG (Arg/Arg) genotype have shown up to a 4.9 times higher risk for type 2 diabetes in certain cohorts, suggesting a profound impact on metabolic health.
• Combined Impact: Individuals carrying risk alleles for both variants often demonstrate higher hunger scores on standardized eating behavior scales and lower resting metabolic rates, leading to a higher predisposition for weight gain.

Mechanistic explanations

These variants disrupt the "leptinostat" at two distinct points: hormone production and signal reception.

• Production (LEP rs7799039): Located in the 5' promoter region, this substitution alters the transcriptional activity of the LEP gene. The A allele acts as a regulatory enhancer, increasing mRNA expression in adipocytes and leading to elevated circulating leptin levels.
• Signaling (LEPR rs1137101): This polymorphism results in a glutamine-to-arginine amino acid swap in the extracellular domain of the leptin receptor. This region is vital for receptor dimerization and the activation of the JAK2/STAT3 signaling pathway. The arginine variant is believed to reduce signaling efficiency, contributing to a state of central leptin resistance.
• Hypothalamic Integration: Under normal conditions, leptin binds to receptors in the arcuate nucleus of the hypothalamus, inhibiting appetite-stimulating neurons (NPY/AgRP) and activating appetite-suppressing neurons (POMC). These genetic variants weaken this feedback loop, resulting in persistent hunger and reduced energy expenditure.

Bottom line

The LEP rs7799039 and LEPR rs1137101 variants are scientifically supported as factors that influence leptin production and receptor sensitivity. Together, they can impair the body's ability to sense satiety and regulate energy balance, increasing the genetic predisposition for obesity and metabolic dysfunction.